FR993M - - Google Patents

Info

Publication number
FR993M
FR993M FR850341A FR850341A FR993M FR 993 M FR993 M FR 993M FR 850341 A FR850341 A FR 850341A FR 850341 A FR850341 A FR 850341A FR 993 M FR993 M FR 993M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR850341A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR993M publication Critical patent/FR993M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR850341A 1960-01-22 1961-01-20 Active FR993M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4001A US3086027A (en) 1960-01-22 1960-01-22 19-nor-4, 9(10)-steroids and process

Publications (1)

Publication Number Publication Date
FR993M true FR993M (fr) 1961-12-11

Family

ID=21708638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR850341A Active FR993M (fr) 1960-01-22 1961-01-20

Country Status (6)

Country Link
US (1) US3086027A (fr)
BE (1) BE599411A (fr)
CH (1) CH402846A (fr)
FR (1) FR993M (fr)
GB (1) GB956251A (fr)
OA (1) OA03370A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250793A (en) * 1963-06-19 1966-05-10 Merck & Co Inc 17alpha-halogenated hydrocarbon derivatives of estra-4, 9-diene 3beta, 17-diols
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same
US3424745A (en) * 1964-05-27 1969-01-28 Roussel Uclaf Novel process for the preparation of trienic steroid derivatives
BE665514A (fr) * 1964-06-16
NL6517141A (fr) * 1964-12-31 1966-07-04
NL127071C (fr) * 1964-12-31
US3370071A (en) * 1965-06-01 1968-02-20 Merck & Co Inc 3-keto-13beta-alkyl-17beta-acetyl-gona-4, 9-dienes and process
US3424768A (en) * 1965-08-17 1969-01-28 Searle & Co 17alpha-alkynylestra-4,9(10)-diene-3beta,17beta-diols and esters thereof
US3423404A (en) * 1965-10-21 1969-01-21 Searle & Co (optionally 17-alkylated) estra-4,9(10)-diene - 3alpha/3beta,17beta - diols and esters corresponding
GB1108276A (en) * 1966-03-14 1968-04-03 British Drug Houses Ltd 17ª‡-alka-1',3'-diynyl-oestra-4,9(10)-dien-3-ones
US3424769A (en) * 1966-04-04 1969-01-28 Syntex Corp Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids
US3461118A (en) * 1966-10-17 1969-08-12 Syntex Corp 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
US3761591A (en) * 1970-02-20 1973-09-25 Roussel Uclaf Novel pregnadiene
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament
US4157349A (en) * 1978-03-13 1979-06-05 Sterling Drug Inc. Dehydrohalogenation process
DE3027908A1 (de) * 1980-07-21 1982-03-18 Schering Ag, 1000 Berlin Und 4619 Bergkamen 16 (beta) -ethylsteroide, diese enthaltende praeparate und verfahren zu ihrer herstellung
FR2495621A1 (fr) * 1980-12-05 1982-06-11 Roussel Uclaf Nouveaux derives de l'estra 4,9-diene, leur procede de preparation et leur application comme medicaments
WO2000053619A1 (fr) * 1999-03-08 2000-09-14 Akzo Nobel N.V. Derives de 14.beta., alpha-hydroxymethylandrostane intervenant comme androgenes
KR100730010B1 (ko) 1999-12-02 2007-06-20 엔.브이.오가논 신규 안드로겐
PL202999B1 (pl) * 1999-12-02 2009-08-31 Organon Nv Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729654A (en) * 1954-05-19 1956-01-03 Searle & Co 10-hydroxy-3-ketosteroids

Also Published As

Publication number Publication date
US3086027A (en) 1963-04-16
BE599411A (fr) 1961-07-24
OA03370A (fr) 1970-12-15
GB956251A (en) 1964-04-22
CH402846A (de) 1965-11-30

Similar Documents

Publication Publication Date Title
BE604029A (fr)
FR993M (fr)
DE1234811C2 (fr)
DE1302648B (fr)
DE1134594C2 (fr)
FI42783B (fr)
FI41155B (fr)
DE1234064C2 (fr)
BE601704A (fr)
FI44094B (fr)
FR1220538A (fr)
FI40498B (fr)
FI40640B (fr)
FI40014B (fr)
FI46289B (fr)
DE1167984C2 (fr)
FI40960B (fr)
CH268061A4 (fr)
DE1440270A1 (fr)
BE610141A (fr)
BE603613A (fr)
BE608878A (fr)
BE608961A (fr)
BE609410A (fr)
BE604953A (fr)